PT  - JOURNAL ARTICLE
AU  - Butler-Laporte, Guillaume
AU  - Povysil, Gundula
AU  - Kosmicki, Jack A.
AU  - Cirulli, Elizabeth T
AU  - Drivas, Theodore
AU  - Furini, Simone
AU  - Saad, Chadi
AU  - Schmidt, Axel
AU  - Olszewski, Pawel
AU  - Korotko, Urszula
AU  - Quinodoz, Mathieu
AU  - Çelik, Elifnaz
AU  - Kundu, Kousik
AU  - Walter, Klaudia
AU  - Jung, Junghyung
AU  - Stockwell, Amy D
AU  - Sloofman, Laura G
AU  - Jordan, Daniel M.
AU  - Thompson, Ryan C.
AU  - Valle, Diane Del
AU  - Simons, Nicole
AU  - Cheng, Esther
AU  - Sebra, Robert
AU  - Schadt, Eric E.
AU  - Schulze-Kim, Seunghee
AU  - Gnjatic, Sacha
AU  - Merad, Miriam
AU  - Buxbaum, Joseph D.
AU  - Beckmann, Noam D.
AU  - Charney, Alexander W.
AU  - Przychodzen, Bartlomiej
AU  - Chang, Timothy
AU  - Pottinger, Tess D
AU  - Shang, Ning
AU  - Brand, Fabian
AU  - Fava, Francesca
AU  - Mari, Francesca
AU  - Chwialkowska, Karolina
AU  - Niemira, Magdalena
AU  - Pula, Szymon
AU  - Baillie, J Kenneth
AU  - Stuckey, Alex
AU  - Salas, Antonio
AU  - Bello, Xabier
AU  - Pardo-Seco, Jacobo
AU  - Gómez-Carballa, Alberto
AU  - Rivero-Calle, Irene
AU  - Martinón-Torres, Federico
AU  - Ganna, Andrea
AU  - Karczewski, Konrad J
AU  - Veerapen, Kumar
AU  - Bourgey, Mathieu
AU  - Bourque, Guillaume
AU  - Eveleigh, Robert JM
AU  - Forgetta, Vincenzo
AU  - Morrison, David
AU  - Langlais, David
AU  - Lathrop, Mark
AU  - Mooser, Vincent
AU  - Nakanishi, Tomoko
AU  - Frithiof, Robert
AU  - Hultström, Michael
AU  - Lipcsey, Miklos
AU  - Marincevic-Zuniga, Yanara
AU  - Nordlund, Jessica
AU  - Schiabor Barrett, Kelly M.
AU  - Lee, William
AU  - Bolze, Alexandre
AU  - White, Simon
AU  - Riffle, Stephen
AU  - Tanudjaja, Francisco
AU  - Sandoval, Efren
AU  - Neveux, Iva
AU  - Dabe, Shaun
AU  - Casadei, Nicolas
AU  - Motameny, Susanne
AU  - Alaamery, Manal
AU  - Massadeh, Salam
AU  - Aljawini, Nora
AU  - Almutairi, Mansour S.
AU  - Arabi, Yaseen M.
AU  - Alqahtan, Saleh A.
AU  - Harthi, Fawz S. Al
AU  - Almutairi, Amal
AU  - Alqubaishi, Fatima
AU  - Alotaibi, Sarah
AU  - Binowayn, Albandari
AU  - Alsolm, Ebtehal A.
AU  - Bardisy, Hadeel El
AU  - Fawzy, Mohammad
AU  - ,
AU  - ,
AU  - ,
AU  - ,
AU  - ,
AU  - ,
AU  - ,
AU  - ,
AU  - Geschwind, Daniel H
AU  - Arteaga, Stephanie
AU  - Stephens, Alexis
AU  - Butte, Manish J.
AU  - Boutros, Paul C.
AU  - Yamaguchi, Takafumi N.
AU  - Tao, Shu
AU  - Eng, Stefan
AU  - Sanders, Timothy
AU  - Tung, Paul J.
AU  - Broudy, Michael E.
AU  - Pan, Yu
AU  - Gonzalez, Alfredo
AU  - Chavan, Nikhil
AU  - Johnson, Ruth
AU  - Pasaniuc, Bogdan
AU  - Yaspan, Brian
AU  - Smieszek, Sandra
AU  - Rivolta, Carlo
AU  - Bibert, Stephanie
AU  - Bochud, Pierre-Yves
AU  - Dabrowski, Maciej
AU  - Zawadzki, Pawel
AU  - Sypniewski, Mateusz
AU  - Kaja, Elżbieta
AU  - Chariyavilaskul, Pajaree
AU  - Nilaratanakul, Voraphoj
AU  - Hirankarn, Nattiya
AU  - Shotelersuk, Vorasuk
AU  - Pongpanich, Monnat
AU  - Phokaew, Chureerat
AU  - Chetruengchai, Wanna
AU  - Tokunaga, Katsuhi
AU  - Sugiyama, Masaya
AU  - Kawai, Yosuke
AU  - Hasegawa, Takanori
AU  - Naito, Tatsuhiko
AU  - Namkoong, Ho
AU  - Edahiro, Ryuya
AU  - Kimura, Akinori
AU  - Ogawa, Seishi
AU  - Kanai, Takanori
AU  - Fukunaga, Koichi
AU  - Okada, Yukinori
AU  - Imoto, Seiya
AU  - Miyano, Satoru
AU  - Mangul, Serghei
AU  - Abedalthagafi, Malak S
AU  - Zeberg, Hugo
AU  - Grzymski, Joseph J
AU  - Washington, Nicole L
AU  - Ossowski, Stephan
AU  - Ludwig, Kerstin U
AU  - Schulte, Eva C
AU  - Riess, Olaf
AU  - Moniuszko, Marcin
AU  - Kwasniewski, Miroslaw
AU  - Mbarek, Hamdi
AU  - Ismail, Said I
AU  - Verma, Anurag
AU  - Goldstein, David B
AU  - Kiryluk, Krzysztof
AU  - Renieri, Alessandra
AU  - Ferreira, Manuel A.R.
AU  - Richards, J Brent
TI  - Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative
AID  - 10.1101/2022.03.28.22273040
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.03.28.22273040
4099  - http://medrxiv.org/content/early/2022/07/20/2022.03.28.22273040.short
4100  - http://medrxiv.org/content/early/2022/07/20/2022.03.28.22273040.full
AB  - Host genetics is a key determinant of COVID-19 outcomes. Previously, the COVID-19 Host Genetics Initiative genome-wide association study used common variants to identify multiple loci associated with COVID-19 outcomes. However, variants with the largest impact on COVID-19 outcomes are expected to be rare in the population. Hence, studying rare variants may provide additional insights into disease susceptibility and pathogenesis, thereby informing therapeutics development. Here, we combined whole-exome and whole-genome sequencing from 21 cohorts across 12 countries and performed rare variant exome-wide burden analyses for COVID-19 outcomes. In an analysis of 5,085 severe disease cases and 571,737 controls, we observed that carrying a rare deleterious variant in the SARS-CoV-2 sensor toll-like receptor TLR7 (on chromosome X) was associated with a 5.3-fold increase in severe disease (95% CI: 2.75-10.05, p=5.41×10−7). This association was consistent across sexes. These results further support TLR7 as a genetic determinant of severe disease and suggest that larger studies on rare variants influencing COVID-19 outcomes could provide additional insights.Author Summary COVID-19 clinical outcomes vary immensely, but a patient’s genetic make-up is an important determinant of how they will fare against the virus. While many genetic variants commonly found in the populations were previously found to be contributing to more severe disease by the COVID-19 Host Genetics Initiative, it isn’t clear if more rare variants found in less individuals could also play a role. This is important because genetic variants with the largest impact on COVID-19 severity are expected to be rarely found in the population, and these rare variants require different technologies to be studies (usually whole-exome or whole-genome sequencing). Here, we combined sequencing results from 21 cohorts across 12 countries to perform a rare variant association study. In an analysis comprising 5,085 participants with severe COVID-19 and 571,737 controls, we found that the gene for toll-like receptor 7 (TLR7) on chromosome X was an important determinant of severe COVID-19. Importantly, despite being found on a sex chromosome, this observation was consistent across both sexes.Competing Interest StatementSee Suppl. Table 2.Funding StatementSee Suppl. Tables 2-4.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:See Suppl. Table 1-2.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe exome-wide burden test summary statistics are available in the Supplements. The single variant association studies summary statistics will be made available openly on the GWAS Catalog following publication.